NCT03146611View on ClinicalTrials.gov

nCD64 vs. Neutrophil/Lymphocyte Ratio for Predicting In-hospital Outcome in AE-COPD

CompletedOBSERVATIONAL
Enrollment

75

Participants

Timeline

Start Date

March 11, 2016

Primary Completion Date

March 1, 2017

Study Completion Date

April 20, 2017

Conditions
COPD ExacerbationCopd
Interventions
DIAGNOSTIC_TEST

nCD64

neutrophil CD64

DIAGNOSTIC_TEST

Neutrophil/Lymphocyte Ratio

Neutrophil/ lymphocyte ratio

Trial Locations (1)

71111

AssiutU, Asyut

All Listed Sponsors
lead

Assiut University

OTHER

NCT03146611 - nCD64 vs. Neutrophil/Lymphocyte Ratio for Predicting In-hospital Outcome in AE-COPD | Biotech Hunter | Biotech Hunter